These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15768841)

  • 1. Identification of 11-Nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine by ion trap GC-MS-MS in the context of doping analysis.
    Caballero GM; D'Angelo C; Fraguío MS; Centurión OT
    J Chromatogr Sci; 2004; 42(10):540-4. PubMed ID: 15768841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of 11 -nor-delta9-tetrahydrocannabinol-9-carboxylic acid with GC-MS in urine collected for doping analysis.
    De Cock KJ; Delbeke FT; De Boer D; Van Eenoo P; Roels K
    J Anal Toxicol; 2003 Mar; 27(2):106-9. PubMed ID: 12670005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of 11-nor-delta 9-tetrahydrocannabinol in urine as its t-butyldimethylsilyl derivative using GC/MS.
    Clouette R; Jacob M; Koteel P; Spain M
    J Anal Toxicol; 1993; 17(1):1-4. PubMed ID: 8381495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory.
    Robandt PV; Klette KL; Sibum M
    J Anal Toxicol; 2009 Oct; 33(8):456-60. PubMed ID: 19874652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced selectivity in the determination of delta9-tetrahydrocannabinol and two major metabolites in serum using ion-trap GC-MS-MS.
    Weller JP; Wolf M; Szidat S
    J Anal Toxicol; 2000; 24(5):359-64. PubMed ID: 10926360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry.
    Jamerson MH; Welton RM; Morris-Kukoski CL; Klette KL
    J Anal Toxicol; 2005 Oct; 29(7):664-8. PubMed ID: 16419397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid method for the GC/MS confirmation of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine.
    Baker TS; Harry JV; Russell JW; Myers RL
    J Anal Toxicol; 1984; 8(6):255-9. PubMed ID: 6097767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization.
    Tai SS; Welch MJ
    J Anal Toxicol; 2000 Sep; 24(6):385-9. PubMed ID: 10999343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas chromatography-mass spectrometry-single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine.
    Boldis O; Kocsis G; Gachályi A; Furész J
    J Chromatogr Sci; 2003 Apr; 41(4):190-4. PubMed ID: 12803806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference by ritodrine in GC/MS confirmation of delta-9-tetrahydrocannabinol-9-carboxylic acid in urine.
    Podkowik BI; Repka ML; Smith ML
    Clin Chem; 1991 Jul; 37(7):1305-6. PubMed ID: 1649709
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated extraction of 11-nor-delta9-tetrahydrocannabinol carboxylic acid from urine samples using the ASPEC XL solid-phase extraction system.
    Langen MC; de Bijl GA; Egberts AC
    J Anal Toxicol; 2000 Sep; 24(6):433-7. PubMed ID: 10999349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple quantitation of formoterol and 11-nor-Δ(9)-tetrahydrocannabinol-9-carboxylic acid in human urine by liquid chromatography-tandem mass spectrometry in doping control.
    Lee KM; Kim HJ; Son J; Park JH; Kwon OS; Lee J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():8-12. PubMed ID: 25063922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of delta9-tetrahydrocannabinol and metabolite in whole blood and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using disposable pipette extraction with confirmation and quantification by gas chromatography-mass spectrometry.
    Schroeder JL; Marinetti LJ; Smith RK; Brewer WE; Clelland BL; Morgan SL
    J Anal Toxicol; 2008 Oct; 32(8):659-66. PubMed ID: 19007518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel solid-phase extraction protocol for 11-nor-9-carboxy-delta9-tetrahydrocannabinol from urine samples employing a polymeric mixed-mode cation-exchange resin, Strata-X-C, suitable for gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry analysis.
    Huq S; Dixon A; Kelly K; Kallury KM
    J Chromatogr A; 2005 May; 1073(1-2):355-61. PubMed ID: 15909541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of World Anti-Doping Agency criteria for anabolic agent analysis by using comprehensive two-dimensional gas chromatography-mass spectrometry.
    Mitrevski BS; Wilairat P; Marriott PJ
    Anal Bioanal Chem; 2010 Apr; 396(7):2503-11. PubMed ID: 20091298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of clenbuterol in human urine by GC-MS-MS-MS: confirmation analysis in antidoping control.
    Amendola L; Colamonici C; Rossi F; Botrè F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):7-16. PubMed ID: 12015265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New catalytic ultrasound method for derivatization of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in urine, with analysis by GC-MS/MS.
    Prata Vde M; Emídio ES; Dorea HS
    Anal Bioanal Chem; 2012 Apr; 403(2):625-32. PubMed ID: 22367244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis.
    Chebbah C; Pozo OJ; Deventer K; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2010 Apr; 24(8):1133-41. PubMed ID: 20301101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatography/tandem mass spectrometry measurement of delta 9-tetrahydrocannabinol, naltrexone, and their active metabolites in plasma.
    Nelson CC; Fraser MD; Wilfahrt JK; Foltz RL
    Ther Drug Monit; 1993 Dec; 15(6):557-62. PubMed ID: 8122294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.